Synthorx, Inc. Contracts & Agreements
24 Contracts & Agreements
- Business Finance (6 contracts)
- Business Operations (2)
- Human Resources (5)
- Intellectual Property (3)
- Mergers & Acquisitions (1)
- Real Estate (3)
- Uncategorized (4)
- Agreement and Plan of Merger, dated as of December 7, 2019, by and among Synthorx, Inc., Sanofi and Thunder Acquisition Corp (Filed With SEC on December 9, 2019)
- Second Amendment to License Agreement, dated August 5, 2019 by and between the Registrant and The Scripps Research Institute (Filed With SEC on November 5, 2019)
- Fifth Amendment to Research Funding and Option Agreement dated July 31, 2019, by and between the Registrant and The Scripps Research Institute (Filed With SEC on November 5, 2019)
- Sub-Sublease Agreement dated August 30, 2019, by and between the Registrant and Avelas Biosciences, Inc (Filed With SEC on November 5, 2019)
- Form of Underwriting Agreement (Filed With SEC on November 27, 2018)
- Form of Common Stock Certificate of the Registrant (Filed With SEC on November 27, 2018)
- Synthorx, Inc. 2018 Equity Incentive Plan and Forms of Stock Option Grant Notice, Option Agreement, Notice of Exercise, Restricted Stock Unit Grant Notice and Restricted Stock... (Filed With SEC on November 27, 2018)
- Synthorx, Inc. 2018 Employee Stock Purchase Plan (Filed With SEC on November 27, 2018)
- Non-Employee Director Compensation Policy (Filed With SEC on November 27, 2018)
- Amended and Restated Investors Rights Agreement, dated April 12, 2018, by and among the Registrant and certain of its stockholders (Filed With SEC on November 13, 2018)
- Form of Indemnity Agreement by and between the Registrant and its directors and officers (Filed With SEC on November 13, 2018)
- Synthorx, Inc. 2014 Equity Incentive Plan and Forms of Option Grant Notice, Option Agreement, Notice of Exercise and Early Exercise Stock Purchase Agreement thereunder, as amended (Filed With SEC on November 13, 2018)
- Synthorx, Inc. 2018 Change in Control and Severance Benefit Plan (Filed With SEC on November 13, 2018)
- License Agreement, dated July 31, 2014, by and between the Registrant and The Scripps Research Institute (Filed With SEC on November 13, 2018)
- Research Funding and Option Agreement, dated July 31, 2014, by and between the Registrant and The Scripps Research Institute, as amended on September 2, 2015, September 9, 2016,... (Filed With SEC on November 13, 2018)
- Master Services Agreement and Scope of Work for Contract Manufacturing Services, dated April 12, 2018, by and between the Registrant and Cytovance Biologics, Inc (Filed With SEC on November 13, 2018)
- Support Services Agreement, dated October 10, 2017, by and between the Registrant and COI Pharmaceuticals, Inc (Filed With SEC on November 13, 2018)
- Office Sublease, dated May 6, 2014, by and between the Registrant and COI Pharmaceuticals, Inc (Filed With SEC on November 13, 2018)
- Offer Letter Agreement, dated October 19, 2017, by and between the Registrant and Laura Shawver, Ph.D (Filed With SEC on November 13, 2018)
- Employment Agreement, dated July 14, 2017, by and between the Registrant and Marcos Milla, Ph.D (Filed With SEC on November 13, 2018)
- Offer Letter Agreement, dated July 20, 2018, by and between the Registrant and Joseph A. Leveque, Ph.D (Filed With SEC on November 13, 2018)
- First Amendment to License Agreement, dated September 10, 2018, by and between the Registrant and The Scripps Research Institute (Filed With SEC on November 13, 2018)
- Lease, dated September 21, 2018, by and between the Registrant and HCP Torrey Pines, LLC (Filed With SEC on November 13, 2018)
- Amendment to Office Sublease, dated November 12, 2018, by and between the Registrant and COI Pharmaceuticals, Inc (Filed With SEC on November 13, 2018)